Recent advances in technology allow us to consider the epigenome as well as the genome of a tumour on an individual level. These advances, in combination with high throughput technologies, are leading to rapid advances in the development of epigenetic biomarkers and novel therapeutic targets.
Who should attend?
This conference will cover some of the most recent advances and cutting edge research in the field of epigenetics and its relationship to cancer. We have created a programme that brings together basic scientists with translational and clinical researchers. During the meeting, there will be great opportunities for young scientists to meet the experts in the field, and we aim to create an open and engaging environment for discussion.
Topics to be covered include:
Epigenetic pathways
Epigenetics and senescence, aging and cancer
Epigenetics and genome stability
Epigenomics
Drugging the epigenome
We look forward to welcoming you to Berlin for this exciting conference.
Who should attend?
This conference will cover some of the most recent advances and cutting edge research in the field of epigenetics and its relationship to cancer. We have created a programme that brings together basic scientists with translational and clinical researchers. During the meeting, there will be great opportunities for young scientists to meet the experts in the field, and we aim to create an open and engaging environment for discussion.
Topics to be covered include:
Epigenetic pathways
Epigenetics and senescence, aging and cancer
Epigenetics and genome stability
Epigenomics
Drugging the epigenome
We look forward to welcoming you to Berlin for this exciting conference.
